Complete clinical response to combined antifungal therapy in two cats with invasive fungal rhinosinusitis caused by cryptic Aspergillus species in section Fumigati

Alexandra Kay (Co-first Author), Lara Boland (Co-first Author), Sarah E. Kidd, Julia A. Beatty, Jessica J. Talbot, Vanessa R. Barrs*

*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

9 Citations (Scopus)
68 Downloads (CityUHK Scholars)

Abstract

Cryptic species in Aspergillus section Fumigati are increasingly reported to cause invasive aspergillosis in humans and animals. These infections are often refractory to treatment because of intrinsic antifungal resistance. We report two cases of invasive fungal rhinosinusitis in domestic cats caused by A. udagawae and A. felis. Clinical signs resolved after combined therapy including posaconazole, caspofungin and terbinafine. Both cases remained asymptomatic more than 2 years from initial presentation.
Original languageEnglish
Pages (from-to)13-17
JournalMedical Mycology Case Reports
Volume34
Online published2 Sept 2021
DOIs
Publication statusPublished - Dec 2021

Research Keywords

  • Aspergillosis
  • Caspofungin
  • Cryptic species
  • Sino-nasal
  • Sino-orbital

Publisher's Copyright Statement

  • This full text is made available under CC-BY-NC-ND 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/

Fingerprint

Dive into the research topics of 'Complete clinical response to combined antifungal therapy in two cats with invasive fungal rhinosinusitis caused by cryptic Aspergillus species in section Fumigati'. Together they form a unique fingerprint.

Cite this